[1] Ross R. Cell biology of atherosclerosis[J]. Annual review of physiology, 1995, 57(1): 791-804.
[2] Rafieian-Kopaei M, Setorki M, Doudi M, et al. Atherosclerosis: process, indicators, risk factors and new hopes[J]. International journal of preventive medicine, 2014, 5(8): 927.
[3] Furie B, Furie B C. Mechanisms of thrombus formation[J]. New England Journal of Medicine, 2008, 359(9): 938-949.
[4] Friedman M, Van den Bovenkamp G J. The pathogenesis of a coronary thrombus[J]. The American journal of pathology, 1966, 48(1): 19.
[5] Sprague A H, Khalil R A. Inflammatory cytokines in vascular dysfunction and vascular disease[J]. Biochemical pharmacology, 2009, 78(6): 539-552.
[6] Assessment R. Major lipids, apolipoproteins, and risk of vascular disease[J]. Jama, 2009, 302(18): 1993-2000.
[7] Sawabe M. Vascular aging: from molecular mechanism to clinical significance[J]. Geriatrics & gerontology international, 2010, 10: S213-S220.
[8] Bao C, Yang Z, Li Q, et al. Aerobic endurance exercise ameliorates renal vascular sclerosis in aged mice by regulating PI3K/AKT/mTOR signaling pathway[J]. DNA and cell biology, 2020, 39(2): 310-320.
[9] Camelo C, Luschnig S. Cells into tubes: Molecular and physical principles underlying lumen formation in tubular organs[M]//Current Topics in Developmental Biology. Academic Press, 2021, 143: 37-74.
